Kuba, A., Szotkowski, T. and Rohon, P. (2015) Spontaneous Splenic Rupture in a Patient with Acute Promyelocytic Leukaemia during Induction Chemotherapy. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 159, 294-298.
https://doi.org/10.5507/bp.2013.086

has been cited by the following article:

• TITLE: Successful Treatment of Spontaneous Rupture of the Spleen by Embolization of Splenic Artery in a Patient with Acute Promyelocytic Leukaemia and COVID-19 Infection

  AUTHORS: Olivera Markovic, Anica Divac, Filip Lukic, Davor Mrda, Ana Vidovic, Marija Zdravkovic, Borislav Toskovic

  KEYWORDS: Acute Promyelocytic Leukaemia, COVID-19, Embolisation of Splenic Artery, Splenic Rupture

  JOURNAL NAME: Open Journal of Emergency Medicine, Vol.9 No.3, July 6, 2021

  ABSTRACT: Spontaneous rupture of the spleen (SRS) is a rare clinical entity with a potentially poor medical outcome. In most cases, SRS is caused by neoplastic disorder. Acute promyelocytic leukaemia is a rare but important cause of SRS that physicians are required to assess for. We present a 28-year-old woman with APL and COVID-19 pneumonia, who successfully underwent embolisation of the splenic artery for spontaneously occurring splenic rupture during induction chemotherapy. After the intervention the patient completed induction chemotherapy and achieved complete remission. Our case demonstrates that emergent transcatheter arterial embolisation can be lifesaving even in the unfavourable condition of a patient with severe immune deficiency.